RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-8.24%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.44B
AUM Growth
+$3.44B
(-14%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
3.85%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
142
New
7
Increased
68
Reduced
12
Closed
10
Top Buys
| 1 |
Align Technology
ALGN
|
$32.7M |
| 2 |
DexCom
DXCM
|
$27.5M |
| 3 |
Humana
HUM
|
$27M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
$25.6M |
| 5 |
Penumbra
PEN
|
$24.5M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$94M |
| 2 |
Encompass Health
EHC
|
$35.7M |
| 3 |
iRhythm Technologies
IRTC
|
$17.9M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$15.4M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$14.7M |
Sector Composition
| 1 | Healthcare | 96.7% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.47% |
| 4 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Humana
HUM
$36.5B
| $200M | 5.81% | 426,358 +57,758 | +16% | +$27M |
|
2
Agilon Health
AGL
$530M
| $168M | 4.88% | 7,681,000 +41,000 | +0.5% | +$895K |
|
3
UnitedHealth
UNH
$281B
| $138M | 4.01% | 268,500 +28,500 | +12% | +$14.6M |
|
4
argenx
ARGX
$43.6B
| $133M | 3.86% | 350,000 | – | – |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $109M | 3.18% | 1,122,500 +17,500 | +2% | +$1.71M |
|
6
Insulet
PODD
$23.9B
| $109M | 3.18% | 502,000 +20,300 | +4% | +$4.42M |
|
7
Immunocore
IMCR
$1.62B
| $99.7M | 2.9% | 2,671,652 +119,618 | +5% | +$4.46M |
|
8
Evolent Health
EVH
$1.12B
| $84.1M | 2.45% | 2,738,000 +358,000 | +15% | +$11M |
|
|
9
Align Technology
ALGN
$10.3B
| $83.9M | 2.44% | 354,500 +138,000 | +64% | +$32.7M |
|
10
Idexx Laboratories
IDXX
$51.8B
| $78.5M | 2.28% | 223,750 +5,000 | +2% | +$1.75M |
|
11
Ultragenyx Pharmaceutical
RARE
$2.89B
| $65.2M | 1.9% | 1,093,030 +64,921 | +6% | +$3.87M |
|
12
Agios Pharmaceuticals
AGIO
$2.19B
| $64.9M | 1.89% | 2,928,458 +263,183 | +10% | +$5.83M |
|
|
SRRA
13
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $64.6M | 1.88% | 1,174,786 | – | – |
|
14
Intuitive Surgical
ISRG
$170B
| $59.9M | 1.74% | 298,500 | – | – |
|
|
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $59.5M | 1.73% | 746,000 | – | – |
|
16
Pacira BioSciences
PCRX
$1.2B
| $59.3M | 1.73% | 1,017,500 +17,500 | +2% | +$1.02M |
|
17
Edwards Lifesciences
EW
$47.8B
| $57.2M | 1.67% | 602,000 +5,500 | +0.9% | +$523K |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $56.7M | 1.65% | 844,977 +285,243 | +51% | +$19.1M |
|
|
KRTX
19
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $55.9M | 1.63% | 441,893 +9,350 | +2% | +$1.18M |
|
20
Aclaris Therapeutics
ACRS
$209M
| $54.8M | 1.6% | 3,927,149 +62,115 | +2% | +$867K |
|
21
Acadia Healthcare
ACHC
$2.12B
| $51M | 1.48% | 753,500 | – | – |
|
|
22
Penumbra
PEN
$10.6B
| $50M | 1.46% | 401,500 +197,000 | +96% | +$24.5M |
|
|
BPMC
23
DELISTED
Blueprint Medicines
BPMC
| $49.5M | 1.44% | 979,174 +31,459 | +3% | +$1.59M |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $48.5M | 1.41% | 332,500 | – | – |
|
|
SGEN
25
DELISTED
Seagen Inc. Common Stock
SGEN
| $48.1M | 1.4% | 272,000 +1,500 | +0.6% | +$265K |
|